Related Experiment Video
Updated: Mar 13, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma
Hisateru Komatsu1,2, Tomohiro Iguchi1, Takaaki Masuda1
1Department of Surgery, Kyushu University Beppu Hospital, Beppu, Japan.
Background:
The RND1 gene encodes a protein that belongs to the Rho GTPase family, which regulates various cellular functions. Depletion of RND1 expression activates the oncogenic Ras signaling pathway. In this study, we aimed to clarify the clinical significance of RND1 expression in predicting prognosis and to investigate its biological role in human hepatocellular carcinoma (HCC).
Methods:
The association between RND1 expression and clinical outcomes in patients with HCC was analyzed in three independent cohorts: 120 cases resected in our hospital; 370 cases in The Cancer Genome Atlas (TCGA); and 242 cases in GSE14520. Gene set enrichment analysis (GSEA) was also conducted. Finally, knockdown experiments were performed using small interfering RNA (siRNA) in vitro.
Results:
In all cohorts, RND1 expression was decreased as cancer progressed, and was affected by promoter methylation. In our HCC cases, the 5-year overall survival (OS) and recurrence-free survival of patients with low RND1 expression was significantly poorer than those of patients with high RND1 expression. TCGA and GSE14520 analyses provided similar results for OS. Multivariate analysis indicated that RND1 expression was an independent prognostic factor for OS in all three cohorts. Additionally, GSEA showed an inverse correlation between RND1 expression and the Ras signaling activity. In vitro, knockdown of RND1 expression resulted in significant increases in proliferation, invasion, and chemoresistance to cisplatin in HCC cells.
Conclusions:
Reduced RND1 expression in HCC was associated with cancer progression, likely through regulation of the Ras signaling pathway, and may serve as a novel clinical biomarker for predicting prognosis in patients with HCC.
Insights
Reduced RND1 gene expression in hepatocellular carcinoma (HCC) correlates with poorer prognosis and increased cancer progression. This suggests RND1 may be a novel biomarker for predicting patient outcomes in HCC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The RND1 gene encodes a Rho GTPase family protein crucial for cellular functions.
- Decreased RND1 expression is linked to the activation of the oncogenic Ras signaling pathway.
- Hepatocellular carcinoma (HCC) progression involves complex genetic and signaling alterations.
Purpose of the Study:
- To determine the clinical significance of RND1 expression in predicting prognosis for HCC patients.
- To elucidate the biological role of RND1 in the development and progression of human HCC.
- To investigate the relationship between RND1 and the Ras signaling pathway in HCC.
Main Methods:
- Analysis of RND1 expression and clinical outcomes in three independent HCC cohorts (n=692).
- Gene Set Enrichment Analysis (GSEA) to assess pathway correlations.
- In vitro knockdown experiments using small interfering RNA (siRNA) in HCC cells.
Main Results:
- RND1 expression decreased with HCC progression and was influenced by promoter methylation.
- Low RND1 expression was significantly associated with poorer overall survival (OS) and recurrence-free survival.
- RND1 expression showed an inverse correlation with Ras signaling activity; RND1 knockdown increased HCC cell proliferation, invasion, and chemoresistance.
Conclusions:
- Reduced RND1 expression in HCC is linked to cancer progression, potentially via Ras signaling pathway regulation.
- RND1 expression serves as an independent prognostic factor for OS in HCC.
- RND1 may represent a novel clinical biomarker for predicting HCC patient prognosis.
Related Concept Videos
Abnormal Proliferation
The Ras Gene
Ras is a...
lncRNA - Long Non-coding RNAs

